Abstract
Chronic diseases such as diabetes, cardiovascular disorders, and cancer present significant challenges to healthcare systems worldwide. The management of these diseases often requires long-term medication, leading to the need for advanced drug delivery systems (DDS) that offer controlled release, enhanced bioavailability, and reduced side effects. Emerging drug delivery technologies have focused on improving the efficacy and patient compliance in the treatment of chronic diseases. This paper discusses the various advanced drug delivery technologies, including nanocarriers, liposomes, smart polymers, and targeted delivery systems. It also explores their potential applications, challenges, and future directions in the treatment of chronic conditions.
All articles published in the American Journal of Pharmaceutics are open access and licensed under the Creative Commons Attribution 4.0 International License (CC BY 4.0). This license allows users to:
-
Share — copy and redistribute the material in any medium or format
-
Adapt — remix, transform, and build upon the material for any purpose, even commercially
Under the following terms:
-
Attribution — Appropriate credit must be given, a link to the license must be provided, and any changes must be indicated.
-
Authors retain full copyright of their work.
-
The journal does not restrict reuse of content, provided proper citation of the original publication is made.